Status:
ACTIVE_NOT_RECRUITING
Screening Adults With Obesity to Reduce Heart Failure Events
Lead Sponsor:
Franciscus Gasthuis
Collaborating Sponsors:
Erasmus Medical Center
Star-shl
Conditions:
Obesity
Heart Failure
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
Rationale: Obesity prevalence in Dutch adults increased to 14.2% in 2020. Obesity is strongly associated with cardiovascular disease, especially heart failure (HF). HF is a serious condition with sig...
Detailed Description
INTRODUCTION AND RATIONALE Obesity (body mass index (BMI) ≥30 kg/m2) prevalence in Dutch adults increased to 14.2% in 2020. In Rotterdam this percentage is even higher. Obesity is strongly associated...
Eligibility Criteria
Inclusion
- Age ≥45 year
- BMI ≥30 kg/m2
- Written informed consent.
Exclusion
- Known cardiac disease (determined by asking the patient and by assessment of the available patient files).
- Treatment with weight-reducing medication.
Key Trial Info
Start Date :
February 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 8 2026
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT06137261
Start Date
February 26 2024
End Date
July 8 2026
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Franciscus Gasthuis & Vlietland
Rotterdam, Netherlands, 3045 PM